Ophthalmic Drugs Global Market By Application, Type, Component, And Global Forecast 2023-2032| Abbvie Inc. (Allergan), Alcon Inc., Bausch & Lomb Incorporated, F. Hoffmann-La Roche Ltd., Novartis AG,

The Ophthalmic Drugs Global Market Report 2023, provides comprehensive information on the ophthalmic drugs market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.

Learn More On The Ophthalmic Drugs Market’s Growth:

https://www.thebusinessresearchcompany.com/report/ophthalmic-drugs-global-market-report

The global ophthalmic drugs market size is expected to grow from $34.02 billion in 2022 to $36.77 billion in 2023 at a compound annual growth rate (CAGR) of 8.07%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global ophthalmic drugs market size is expected to reach $49.21 billion in 2027 at a CAGR of 7.56%.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample_request?id=10065&type=smp

Product innovations are a key trend gaining popularity in the ophthalmic drug market. Major companies operating in the ophthalmic drug market are focused on developing new solutions to strengthen their position in the market. In January 2022, Sun Pharmaceutical Canada Inc., a Canada-based research and development company that specializes in developing innovative medicines in dermatology and ophthalmology, launched the ophthalmic drug CEQUA (cyclosporine ophthalmic solution 0.09% w/v) for the treatment of dry eye disease in Canada. CEQUA is delivered with nano micellar (NCELL) technology. Nanomicellar technology increases ocular tissue penetration by improving the bioavailability and physicochemical stability of cyclosporine.

The ophthalmic drugs market is segmented:

1) By Type: Prescription Drugs, Over-The-Counter Drugs

2) By Class: Anti-Allergy, Anti-Inflammatory, Anti-Glaucoma, Other Classes

3) By Disease: Dry Eye, Eye Allergy, Glaucoma, Eye Infection, Retinal Disorders, Uveitis, Other Diseases

4) By Dosage Form: Liquid Ophthalmic Drug Forms, Solid Ophthalmic Drug Forms, Semisolid Ophthalmic Drug Forms, Multicompartment Drug Delivery Systems

5) By Distribution Channel: Hospital Pharmacies, Drug Stores, Online Pharmacies

North America was the largest region in the ophthalmic drugs market in 2022.

The table of contents in TBRC’s ophthalmic drugs market report includes

1. Executive Summary

2. Ophthalmic Drugs Market Characteristics

3. Ophthalmic Drugs Market Trends And Strategies

4. Ophthalmic Drugs Market – Macro Economic Scenario

5. Ophthalmic Drugs Market Size And Growth

.

.

.

26. Africa Ophthalmic Drugs Market

27. Ophthalmic Drugs Market Competitive Landscape And Company Profiles

28. Key Mergers And Acquisitions In The Ophthalmic Drugs Market

29. Ophthalmic Drugs Market Future Outlook and Potential Analysis

30. Appendix

Top Major Players:

  • Abbvie Inc.
  • Alcon Inc
  • Bausch & Lomb Incorporated
  • F. Hoffmann-La Roche Ltd
  • Novartis AG

Learn About Us:

The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: [email protected]

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model